1. Home
  2. GTX vs EVO Comparison

GTX vs EVO Comparison

Compare GTX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTX
  • EVO
  • Stock Information
  • Founded
  • GTX 2018
  • EVO 1993
  • Country
  • GTX Switzerland
  • EVO Germany
  • Employees
  • GTX N/A
  • EVO N/A
  • Industry
  • GTX Auto Parts:O.E.M.
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GTX Consumer Discretionary
  • EVO Health Care
  • Exchange
  • GTX Nasdaq
  • EVO Nasdaq
  • Market Cap
  • GTX 1.8B
  • EVO 1.6B
  • IPO Year
  • GTX N/A
  • EVO 2021
  • Fundamental
  • Price
  • GTX $9.02
  • EVO $3.60
  • Analyst Decision
  • GTX Strong Buy
  • EVO Buy
  • Analyst Count
  • GTX 1
  • EVO 2
  • Target Price
  • GTX $12.00
  • EVO $5.90
  • AVG Volume (30 Days)
  • GTX 2.0M
  • EVO 101.3K
  • Earning Date
  • GTX 05-01-2025
  • EVO 04-17-2025
  • Dividend Yield
  • GTX 0.67%
  • EVO N/A
  • EPS Growth
  • GTX N/A
  • EVO N/A
  • EPS
  • GTX 1.26
  • EVO N/A
  • Revenue
  • GTX $3,475,000,000.00
  • EVO $825,103,013.00
  • Revenue This Year
  • GTX N/A
  • EVO $3.70
  • Revenue Next Year
  • GTX $7.85
  • EVO $10.32
  • P/E Ratio
  • GTX $7.16
  • EVO N/A
  • Revenue Growth
  • GTX N/A
  • EVO 1.99
  • 52 Week Low
  • GTX $7.02
  • EVO $2.84
  • 52 Week High
  • GTX $10.39
  • EVO $7.77
  • Technical
  • Relative Strength Index (RSI)
  • GTX 55.97
  • EVO 56.15
  • Support Level
  • GTX $8.84
  • EVO $3.27
  • Resistance Level
  • GTX $9.22
  • EVO $3.40
  • Average True Range (ATR)
  • GTX 0.46
  • EVO 0.14
  • MACD
  • GTX 0.14
  • EVO 0.07
  • Stochastic Oscillator
  • GTX 91.14
  • EVO 84.44

About GTX Garrett Motion Inc.

Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: